Treatment Efficacy and Compliance in Patients with Diabetic Macular Edema Treated with Ranibizumab in a Real-Life Setting

Table 2

Baseline features of retinopathy, maculopathy, and ophthalmologic history.

Eye number
NPDR
Mild	5 (7%)
Moderate	18 (25%)
Severe	20 (27.7%)
PDR	8 (11.1%)
Laser photocoagulation
PRP
Ongoing	22 (30.5%)
Completed	21 (29.1%)
Focal/grid	26 (36.1%)
Intravitreal injection history
Corticosteroids	1 (1.3%)
DME duration (months): mean (±SD)	20.2 (±25.13)
Pseudophakic	18 (25%)
Vitreomacular surgery	4 (5.6%)
Epiretinal membrane	10 (13.8%)
High intraocular pressure history	4 (5.5%)

NPRD: nonproliferative diabetic retinopathy; PDR: proliferative diabetic retinopathy; PRP: panretinal photocoagulation; SD: standard deviation; n: number of eyes.